Adicet Bio Inc. (NASDAQ: ACET) announced that the first systemic sclerosis patient has been dosed in the second cohort of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE